17 jul: Test
24 jul: Bobler fra dybet fik hammerslag på rekordpriser ved nyligt afhold..
19-07-2012 09:27:00

UPDATE: Co-Operative Buys Lloyds Branches, Leapfrogs into Big League

Relateret indhold

--Co-Operative tranforms into major bank player through deal

--Lloyds Sells 632 branches for up to GBP800M, including earn-outs

(Rewrites, adds detail, Co-Operative CEO comment.)

By Max Colchester and Jessica Hodgson

LONDON--The Co-Operative Group (CPBB.LN) said Thursday it will acquire 632 retail bank branches from Lloyds Banking Group PLC (LYG), sealing a long-awaited deal that will transform the funerals-to-food group into the U.K.'s sixth-largest retail banking business.

The Co-Op agreed to pay initial consideration of GBP350 million for the branches, and up to an additional GBP400 million in present value--equivalent to around GBP800 million in total subject to the performance of the Co-Operative groups combined banking businesses over a 15-year period.

The figure is significantly below the estimated GBP1.5 billion that was reportedly offered when discussions began a year ago, reflecting the decline in the value of bank assets over the period.

The Co-Operative, at a stroke, acquires 4.8 million customer accounts through the purchase. Combining this with its existing branch network will give it around 1,000 U.K. bank branches and roughly 7% of all U.K. current accounts, up from its previous share of roughly 2% the Co-Operative said.

The Co-Operative's Group Chief Executive Peter Marks told reporters the acquisition would help deliver "the most significant development in high street banking in a generation," and offer U.K. consumers an alternative to an industry whose image he said had been "badly tarnished," during the financial crisis and by recent events.

Lloyds, which is roughly 40%-owned by the U.K. government, has had to sell the branches on condition of receiving state aid when it was bailed out in 2008. But the sale, code-named Verde, has been dogged by regulatory issues related to the experience of the Co-Op's board and the amount of capital the group would have to hold if it boosted its banking business.

The sale of the branches is heralded by the British government as a way to boost competition in the U.K. banking sector. "This is another step towards creating a new banking system for Britain that gives real choice to customers and supports the economy," George Osborne, the U.K. Chancellor, said in a statement Thursday.

The U.K.'s Independent Commission on Banking said a standalone bank needs to achieve 6% market share in order to be competitive.

"We believe the Co-Operative will be a good owner for our business, customers and colleagues, and the combined banking business will be a significant competitor on the high street with nearly 10% of today's U.K. branch network," Antonio Horta-Osorio, Lloyds' CEO, said in a statement.

Paul Pester, currently CEO of Verde, will become CEO of the combined Co-Op banking business, subject to FSA approval, the Co-Operative said in a statement.

The Lloyds statement said Lloyds was expected to inject the branches with GBP1.5 billion of equity capital. The branches will have approximately GBP11 billion of risk-weighted assets on a standardised basis.

Mr. Marks said on the conference call that he expected the deal to close, subject to regulatory approval, roughly in mid 2013.

-Write to Max Colchester at max.colchester@wsj.com

(Ainsley Thomson in London contributed to this article.)

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

(END) Dow Jones Newswires

July 19, 2012 03:27 ET (07:27 GMT)

Copyright (c) 2012 Dow Jones & Company, Inc.

Opret kommentar

Relateret debat

  • 1 uge
  • 1 måned
  • 1 År
Ingen indlæg

Fondsbørsmeddelelser

Aktier/middag: Genmab buldrer frem med WDH og ISS som følgesvende

22-02-2018 11:40:57
Biotekselskabet Genmab ligger helt i top i det danske eliteindeks torsdag middag efter at have præsenteret regnskab onsdag aften. Også ISS og William Demant, der begge kom med regnskab for fjerde kvartal torsdag morgen, er med i toppen.Men det er onsdagens regnskab fra Genmab, der trækker den helt store opmærksomhed, efter at biotekselskabet gjorde markedets bekymringer over en mulig skuffende pro..

ISS: Salget vokser mens bundlinjen skrumper

22-02-2018 08:39:00
ISS kan se bundlinjen falde tilbage i 2017 sammenlignet med i 2016, selvom selskabet er vokset på salget.Omsætningen i selskabet voksede til 79.912 mio. kr. i 2017, mens omsætningen udgjorde 78.658 mio. kr. i 2016.Omvendt steg nettoresultatet i 2017 til 2007 mio. kr. mod 2220 mio. kr. året før.Af regnskabet fremgår det, at årsagen til at bundlinjen ikke vokser med toplinjen, blandt andet er ekster..

Novo Nordisk: Ozempic optaget på stor indkøbsforenings tilskudsliste

21-02-2018 15:39:04
Novo Nordisks nylancerede ugentlige GLP-1-analog Ozempic er blevet optaget på den amerikanske indkøbsforening Express Scripts nationale tilskudsliste, der gælder for en lang række sygekasser i 2018.Det bekræfter Novo Nordisk over for Ritzau Finans.Optagelsen er et vigtigt skridt i Novos arbejde med at indgå kontrakter med de store indkøbsforeninger, der står for sygekassernes indkøb og også rådgiv..

Mest læste nyheder

  • 24 timer
  • 48 timer
  • 1 uge
1
Mærsk/Sydbank: Aktionærer kan se frem til udbetaling i 2018 eller 2019
2
Genmab/Sydbank: Stærk Darzalex-prognose bør sende aktien op
3
Aktier/åbning: Genmab brager frem og trækker eliteindekset i plus
4
Vestas vinder mølleordre i USA
5
Aktier/tendens: Genmab, ISS og William i fokus i rød handelsstart

Relaterede aktiekurser

Køb- og salgsanbefalinger

  • Trend
  • Pengemaskinen

Copyright Euroinvestor A/S 2018  Disclaimer Privatlivspolitik
Aktieinformation leveres af Interactive Data.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
22. februar 2018 13:33:17
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: ReleaseBuild_20180222.1 - EUROWEB5 - 2018-02-22 13:33:17 - 2018-02-22 13:33:17 - 1 - Website: OKAY